Clinical Trial Update: Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating batoclimab for induction and maintenance therapy in adults with generalized myasthenia gravis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis

Drugs mentioned

• Batoclimab (batoclimab)

Snippet

Sponsor: Immunovant Sciences GmbH | Conditions: Generalized Myasthenia Gravis | Phase 3 | Status: ACTIVE_NOT_RECRUITING